Inhibitory effect of atractylenolide I on angiogenesis in chronic inflammation in vivo and in vitro

European Journal of Pharmacology

Volumn 612, Issue 1-3, 2009, Pages 143-152

  Wang, Changhe ^a   Duan, Haijie ^a   He, Langchong ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Air pouch; Angiogenesis; Atractylenolide I; Chronic inflammation; Co culture

Indexed keywords

ANGIOGENESIS INHIBITOR; ATRACTYLENOLIDE; ATRACTYLODES MACROCEPHALA EXTRACT; INTERLEUKIN 1BETA; INTERLEUKIN 6; NITRIC OXIDE; PLACENTAL GROWTH FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATRACTYLODES MACROCEPHALA; CHRONIC INFLAMMATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENCY; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MALE; MEDICINAL PLANT; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; VASCULAR RING;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTI-INFLAMMATORY AGENTS; AORTA; CHRONIC DISEASE; COCULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMALE; INFLAMMATION; INHIBITORY CONCENTRATION 50; INTERLEUKIN-1BETA; INTERLEUKIN-6; LACTONES; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED BALB C; MICROVESSELS; MOLECULAR STRUCTURE; NEOVASCULARIZATION, PATHOLOGIC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PREGNANCY PROTEINS; SESQUITERPENES; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 65549116590     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.04.001     Document Type: Article

References (48)

1. Balkwill F., and Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 357 (2001) 539-545
2. Beck H., Acker T., Puschel A.W., Fujisawa H., Carmeliet P., and Plate K.H. Cell type-specifi{ligature}c expression of neuropilins in an MCA-occlusion model in mice suggests a potential role in post-ischemic brain remodeling. J. Neuropathol. Exp. Neurol. 61 (2002) 339-350
3. Berse B., Brown L.F., Van de W.L., Dvorak H.F., and Senger D.R. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol. Biol. Cell 3 (1992) 211-220
4. Bocci G., Danesi R., Benelli U., Innocenti F., DiPaolo A., Fogli S., and Del Tacca M. Inhibitory effect of suramin in rat models of angiogenesis in vitro and in vivo. Cancer Chemother. Pharmacol. 43 (1999) 205-212
5. Bryan D., Walker K.B., Ferguson M., and Thorpe R. Cytokine gene expression in a murine wound healing model. Cytokine 31 (2005) 429-438
6. Buttery L.D.K., Springall D.R., Andrade S.P., Riveros-Moreno V., Hart I., Piper P.J., and Polak J.M. Induction of nitric oxide synthase in the neo-vasculature of experimental tumours in mice. J. Pathol. 171 (1993) 311-319
7. Clauss M., Weich H., Breier G., Knies U., Rockl W., Waltenberger J., and Risau W. The vascular endothelial growth factor receptor Flt-1mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J. Biol. Chem. 271 (1996) 17629-17634
8. Devy L., Blacher S., Grignet-Debrus C., Bajou K., Masson V., Gerard R.D., Gils A., Carmeliet G., Carmeliet P., Declerck P.J., Noel A., and Foidart J.M. The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent. FASEB 16 (2002) 147-154
9. Distler J.H.W., Hirth A., Kurowska-Stolarska M., Gay R.E., Gay S., and Distler O. Angiogenic and angiostatic factors in the molecular control of angiogenesis. Nucl. Med. 47 (2003) 149-161
10. Farndale R.W., Buttle D.J., and Barrett A.J. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim. Biophys. Acta 883 (1986) 173-177
11. Ferrara N. Molecular and biological properties of vascular endothelial growth factor. J. Mol. Med. 77 (1999) 527-543
12. Fischer C., Jonckx B., Mazzone M., Zacchigna S., Loges S., Pattarini L., Chorianopoulos E., Liesenborghs L., Koch M., De Mol M., Autiero M., Wyns S., Plaisance S., Moons L., van Rooijen N., Giacca M., Stassen J.M., Dewerchin M., Collen D., and Carmeliet P. Anti-PlGF Inhibits Growth of VEGF(R)-Inhibitor-Resistant Tumors without Affecting Healthy Vessels. Cell 131 (2007) 463-475
13. Gimbrone M.A., Cotran R.S., Leapman S.B., and Folkman J. Tumor growth and neovascularization: an experimental model using the rabbit cornea. J. Natl. Cancer Inst. 52 (1974) 413-427
14. Green L.C., Wagner D.A., Glogowski J., Skipper P.L., Wishnok J.S., and Tannenbaum S.T. Analysis of nitrate, nitrite and (15N) nitrate in biological fluids. Anal. Biochem. 126 (1982) 131-138
15. Griffioen A.W., and Molema G. Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases and chronic inflammation. Pharmacol. Rev. 52 (2000) 237-268
16. Hoeben A., Landuyt B., Highley M.S., Wildiers H., Van Oosterom A.T., and De Bruijn E.A. Vascular endothelial growth factors and angiogenesis. Pharmacol. Rev. 56 (2004) 549-580
17. Huang B.S., Sun J.S., and Chen Z.L. Isolation and identification of atractylenolide VI from Atractylodes macrocephala Koidz. Acta Bot. Sin. 34 (1992) 614-617
18. Huang H.L., Chen C.C., Yeh C.Y., and Huang R.L. Reactive oxygen species mediation of Baizhu-induced apoptosis in human leukemia cells. J. Ethnopharmacol. 97 (2005) 21-29
19. Jackson J.R., Seed M.P., Kircher C.H., Willoughby D.A., and Winkler J.D. The codependence of angiogenesis and chronic inflammation. FASEB J. 11 (1997) 457-465
20. Jackson J.R., Bolognese B., Mangar C.A., Hubbard W.C., Marshall C.A., and Winkler J.D. The role of platelet activating factor and other lipid mediators in inflammatory angiogenesis. Biochim. Biophys. Acta 1392 (1998) 145-152
21. Josko J., and Mazurek M. Transcription factors having impact on vascular endothelial growth factor (VEGF) gene expression in angiogenesis. Med. Sci. Monit. 10 (2004) 89-98
22. Kaori K., Masahiro N., Noriyuki S., and Voshinao W. Expression of vascular endothelial growth Factor, placental growth factor, and their Receptors flt-1 and KDR in human placenta under pathologic conditions. Human Pathol. 33 (2002) 1069-1077
23. Klagsbrun M. Mediators of angiogenesis: the biological significance of basic fibroblast growth factor (bFGF)-heparin and heparan sulfate interactions. Semin. Cancer Biol. 3 (1992) 81-87
24. Knighton D., Ausprunk D., Tapper D., and Folkman J. Avascular and vascular phases of tumor growth in the chick embryo. Br. J. Cancer 35 (1977) 347-356
25. Koch A.E., Polverini P.J., Kunkel S.L., Harlow L.A., Dipietro L.A., Elner V.M., Elner S.G., and Strieter R.M. Interleukin-8 as a macrophagederived mediator of angiogenesis. Science 258 (1992) 1798-1801
26. Laughner E., Taghavi P., Chiles K., Mahon P.C., and Semenza G.L. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol. Cell. Biol. 21 (2001) 3995-4004
27. Leahy K.M., Koki A.T., and Masferrer J.L. Role of cyclooxygenases in angiogenesis. Curr. Med. Chem. 7 (2000) 1163-1170
28. 4 receptor component from Atractylodes macrocephala Koidz. Sci. China, Ser. C Life Sci. 49 (2006) 182-189
29. Li C.Q., He L.C., Dong H.Y., and Jin J.Q. Screening for the anti-inflammatory activity of fractions and compounds from Atractylodes macrocephala koidz. J. Ethnopharmacol. 114 (2007) 212-217
30. Liu Y., Ye F., Qiu G.Q., Zhang M., Wang R., Wang Q.Y., and Cai Y.J. Effects of lactone I from Atractylodes macrocephala Koidz on cytokines and proteolysis-inducing factors in cachectic cancer patients. First Milit. Med. Univ. 25 (2005) 1308-1311
31. Luttun A., Tjwa M., Moons L., Wu Y., Angelillo-Scherrer A., Liao F., Nagy J.A., Hooper A., Priller J., De Klerck B., Compernolle V., Daci E., Bohlen P., Dewerchin M., Herbert J.M., Fava R., Matthys P., Carmeliet G., Collen D., Dvorak H.F., Hicklin D.J., and Carmeliet P. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat. Med. 8 (2002) 831-840
32. Maglione D., Guerriero V., Viglietto G., Dellibovi P., and Persico M.G. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 9267-9271
33. Margaret K., John M., and Paul K. Modulating leukocyte recruitment in infl{ligature}ammation. J. Allergy Clin. Immunol. 120 (2007) 3-10
34. Medina J., Sanz-Cameno P., García-Buey L., Martín-Vilchez S., López-Cabrera M., and Moreno-Otero R. Evidence of angiogenesis in primary biliary cirrhosis: an immunohistochemical descriptive study. J. Hepatol. 42 (2005) 124-131
35. Ng S.S.W., Gutschow M., Weiss M., Hauschildt S., Teubert U., Hecker T.K., Luzzio F.A., Kruger E.A., Eger K., and Figg W.D. Antiangiogenic activity of N-substituted and tetrafluorinated thalidomide analogues. Cancer Res. 63 (2003) 3189-3194
36. Nicosia R.F., and Ottinetti A. Growth of microvessels in serum-free matrix culture of rat aorta: a quantitative assay of angiogenesis in vitro. Lab. Invest. 63 (1990) 115-122
37. Park J.E., Chen H.H., Winer J., Houck K.A., and Ferrara N. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affi{ligature}nity binding to Flt-1 but not to Flk-1/KDR. J. Biol. Chem. 269 (1994) 25646-25654
38. Pepper M.S., Ferrara N., Orci L., and Montesano R. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem. Biophys. Res. Commun. 181 (1991) 902-906
39. Persico M.G., Vincenti V., and Di Palma T. Structure expression and receptor-binding properties of placental growth factor (PlGF). Curr. Top. Microbiol. Immunol. 237 (1999) 31-40
40. Pugh-Humphreys R.G. Macrophage-neoplastic cell interactions: implications for neoplastic cell growth. FEMS Microbiol. Immunol. 5 (1992) 289-308
41. Risau W. Mechanisms of angiogenesis. Nature 386 (1997) 671-674
42. Shin K.Y., Moon H.S., Park H.Y., Lee T.Y., Woo Y.N., Kim H.J., Lee S.J., and Kong G. Effects of tumor necrosis factor-alpha and interferon-gamma on expression of matrix metalloproteinase-2 and -9, in human bladder cancer cells. Cancer Lett. 159 (2000) 127-134
43. Sunderkotter C., Steinbrink K., Goebeler M., Bhardwaj R., and Sorg C. Macrophages and angiogenesis. J. Leukoc. Biol. 55 (1994) 410-422
44. Walsh D.A., and Pearson C.I. Angiogenesis in the pathogenesis of inflammatory joint and lung diseases. Arthritis Res. 31 (2001) 147-153
45. Wang C.C., Lin S.Y., Cheng H.C., and Hou W.C. Pro-oxidant and cytotoxic activities of atractylenolide I in human promyeloleukemic HL-60 cells. Food Chem. Toxicol. 44 (2006) 1308-1315
46. Waterston A., and Bower M. TNF and cancer: good or bad. Cancer Ther. 2 (2004) 131-148
47. Zhang J., Sun Y., Zhang J.Q., Ramires F.J.A., and Weber K.T. Appearance and regression of rat pouch tissue. J. Mol. Cell. Cardiol. 31 (1999) 1005-1013
48. Zhang Y.Q., Xu S.B., and Lin Y.C. Gastrointestinal inhibitory effects of sesquiterpene lactones from Alractylodes macrocephala. Chin. Med. Mater. 22 (1999) 636-640